TaiRx, Inc. (TPEX:6580)
10.60
-0.75 (-6.61%)
Nov 20, 2026, 1:33 PM CST
TaiRx Market Cap
TaiRx has a market cap or net worth of 1.19 billion as of November 20, 2026. It is the 31,952nd most valuable company in the world and the 1,861st biggest in Taiwan. Its market cap has decreased by 50.63% in one year.
Market Cap
1.19B
Enterprise Value
913.75M
Revenue
29.44M
Global Rank
Country Rank
#1,861 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 20, 2017, TaiRx's market cap has decreased from 3.25B to 1.19B, a decrease of -63.44%. That is a compound annual growth rate of -10.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.22B | -49.59% |
| Dec 31, 2025 | 2.42B | -15.03% |
| Dec 31, 2024 | 2.85B | 17.14% |
| Dec 29, 2023 | 2.44B | -27.90% |
| Dec 30, 2022 | 3.38B | -29.76% |
| Dec 30, 2021 | 4.81B | 86.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| U-Neuron Biomedical | 1.42B |
| Anti-Microbial Savior BioteQ | 1.35B |
| GenMont Biotech Incorporation | 1.33B |
| Synbio Tech | 1.32B |
| Greenyn Biotechnology | 1.21B |
| NeoCore Technology | 1.20B |
| MegaPro Biomedical | 1.19B |
| Advagene Biopharma | 1.18B |